Why your serialization investment should deliver more than compliance

For more than a decade, pharmaceutical organizations have invested in serialization and traceability to meet regulatory mandates like the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (EU FMD). In most organizations, those implementations were …